Development of a PCR Lateral Flow Assay for Rapid Detection of Bacillus anthracis, the Causative Agent of Anthrax.


Journal

Molecular biotechnology
ISSN: 1559-0305
Titre abrégé: Mol Biotechnol
Pays: Switzerland
ID NLM: 9423533

Informations de publication

Date de publication:
Aug 2021
Historique:
received: 08 04 2021
accepted: 06 05 2021
pubmed: 14 5 2021
medline: 21 12 2021
entrez: 13 5 2021
Statut: ppublish

Résumé

Bacillus anthracis, the causative agent of anthrax is one of the most potent listed biological warfare agents. The conventional microbiological methods of its detection are labor intensive and time consuming, whereas molecular assays are fast, sensitive and specific. PCR is one of the most reliable diagnostic tools in molecular biology. The combination of PCR with lateral flow strips can reduce the diagnostic/detection time. It gives an alternative to gel electrophoresis and offers easy and clear interpretation of results. In the present study, a PCR Lateral flow (PCR-LF) assay targeting cya gene present on pXO1 plasmid of B. anthracis has been developed. The forward and reverse primers were tagged with 6-carboxyflourescein (6-FAM) and biotin, respectively, at 5' end. The dual labeled PCR products were detected using lateral flow (LF) strips developed in this study. The PCR-LF assay could detect ≥ 5 pg of genomic DNA and ≥ 500 copies of target DNA harboured in a recombinant plasmid. The assay was able to detect as few as 10

Identifiants

pubmed: 33982268
doi: 10.1007/s12033-021-00335-6
pii: 10.1007/s12033-021-00335-6
doi:

Substances chimiques

Antigens, Bacterial 0
Bacterial Toxins 0
DNA, Bacterial 0
anthrax toxin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

702-709

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Spencer, R. C. (2003). Bacillus anthracis. Journal of Clinical Pathology, 56, 182–187
doi: 10.1136/jcp.56.3.182
Goel, A. K. (2015). Anthrax: A disease of biowarfare and public health importance. World Journal of Clinical Cases, 3, 20–33
doi: 10.12998/wjcc.v3.i1.20
Collier, R. J., & Young, J. A. (2003). Anthrax toxin. Annual Review of Cell and Developmental Biology, 19, 45–70
doi: 10.1146/annurev.cellbio.19.111301.140655
Turnbull, P. C. (1999). Definitive identification of Bacillus anthracis—A review. Journal of Applied Microbiology, 87, 237–240
doi: 10.1046/j.1365-2672.1999.00876.x
Welkos, S. L., Keener, T. J., & Gibbs, P. H. (1986). Differences in susceptibility of inbred mice to Bacillus anthracis. Infection and Immunity, 51, 795–800
doi: 10.1128/iai.51.3.795-800.1986
Blažková, M., Koets, M., Rauch, P., & van Amerongen, A. (2009). Development of a nucleic acid lateral flow immunoassay for simultaneous detection of Listeria spp. and Listeria monocytogenes in food. European Food Research and Technology, 229, 867
doi: 10.1007/s00217-009-1115-z
Zhuang, L., Ji, Y., Tian, P., Wang, K., Kou, C., Gu, N., & Zhang, Y. (2019). Polymerase chain reaction combined with fluorescent lateral flow immunoassay based on magnetic purification for rapid detection of canine parvovirus 2. BMC Veterinary Research, 15, 30
doi: 10.1186/s12917-019-1774-3
Takada, K., Sakaguchi, Y., Oka, C., & Hirasawa, M. (2005). New rapid polymerase chain reaction-immunochromatographic assay for Porphyromonas gingivalis. Journal of Periodontology, 76, 508–512
doi: 10.1902/jop.2005.76.4.508
Fayad, N., Kallassy Awad, M., & Mahillon, J. (2019). Diversity of Bacillus cereus sensu lato mobilome. BMC Genomics, 20, 436
doi: 10.1186/s12864-019-5764-4
Marston, C. K., Gee, J. E., Popovic, T., & Hoffmaster, A. R. (2006). Molecular approaches to identify and differentiate Bacillus anthracis from phenotypically similar Bacillus species isolates. BMC Microbiology, 6, 22
doi: 10.1186/1471-2180-6-22
Helgason, E., Okstad, O. A., Caugant, D. A., Johansen, H. A., Fouet, A., Mock, M., Hegna, I., & Kolsto, A. B. (2000). Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis-one species on the basis of genetic evidence. Applied and Environment Microbiology, 66, 2627–2630
doi: 10.1128/AEM.66.6.2627-2630.2000
Ghosh, N., Tomar, I., & Goel, A. K. (2013). A field usable qualitative anti-protective antigen enzyme-linked immunosorbent assay for serodiagnosis of human anthrax. Microbiology and Immunology, 57, 145–149
doi: 10.1111/1348-0421.12014
Ghosh, N., & Goel, A. K. (2012). Anti-protective antigen IgG enzyme-linked immunosorbent assay for diagnosis of cutaneous anthrax in India. Clinical and Vaccine Immunology, 19, 1238–1242
doi: 10.1128/CVI.00154-12
Varshney, A., Puranik, N., Kumar, M., Pal, V., Padmaja, J., & Goel, A. K. (2019). An ELISA using a recombinant chimera of protective antigen and lethal factor for serodiagnosis of cutaneous anthrax in India. Biologicals, 57, 55–60
doi: 10.1016/j.biologicals.2019.01.001
Puranik, N., Kumar, M., Tripathi, N., Pal, V., & Goel, A. K. (2019). A rapid flow through membrane enzyme linked immunosorbent assay for Bacillus anthracis using surface array protein as a biomarker. Defence Science Journal, 69, 348–352
doi: 10.14429/dsj.69.13730
Koczula, K. M., & Gallotta, A. (2016). Lateral flow assays. Essays in Biochemistry, 60, 111–120
doi: 10.1042/EBC20150012
Puranik, N., Pal, V., Tripathi, N. K., & Goel, A. K. (2020). Development of a rapid immunochromatographic assay for detection of surface array protein (Sap), a potent biomarker of Bacillus anthracis. Biologia, 75, 613–617
doi: 10.2478/s11756-019-00379-9
Gates-Hollingsworth, M. A., Perry, M. R., Chen, H., Needham, J., Houghton, R. L., Raychaudhuri, S., Hubbard, M. A., & Kozel, T. R. (2015). Immunoassay for capsular antigen of Bacillus anthracis enables rapid diagnosis in a rabbit model of inhalational anthrax. PLoS ONE, 10, e0126304
doi: 10.1371/journal.pone.0126304
Buscher, P. (2011). Nucleic acid lateral flow tests for molecular diagnosis: An update. Expert Opinion on Medical Diagnostics, 5, 85–89
doi: 10.1517/17530059.2011.542143
Zhang, P., Liu, X., Wang, C., Zhao, Y., Hua, F., Li, C., Yang, R., & Zhou, L. (2014). Evaluation of up-converting phosphor technology-based lateral flow strips for rapid detection of Bacillus anthracis spore, Brucella spp., and Yersinia pestis. PLoS ONE, 9, e105305
doi: 10.1371/journal.pone.0105305
Baeumner, A. J., Leonard, B., McElwee, J., & Montagna, R. A. (2004). A rapid biosensor for viable B. anthracis spores. Analytical and Bioanalytical Chemistry, 380, 15–23
doi: 10.1007/s00216-004-2726-7
Leppla, S. H. (1982). Anthrax toxin edema factor: A bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells. Proceedings of National Academy of Sciences USA, 79, 3162–3166
doi: 10.1073/pnas.79.10.3162
Pena-Gonzalez, A., Rodriguez, R. L., Marston, C. K., Gee, J. E., Gulvik, C. A., Kolton, C. B., Saile, E., Frace, M., Hoffmaster, A. R., & Konstantinidis, K. T. (2018). Genomic characterization and copy number variation of Bacillus anthracis plasmids pXO1 and pXO2 in a historical collection of 412 strains. mSystems. https://doi.org/10.1128/mSystems.00065-18
doi: 10.1128/mSystems.00065-18 pubmed: 30116789 pmcid: 6093989
Liang, X., Zhang, H., Zhang, E., Wei, J., Li, W., Wang, B., Dong, S., & Zhu, J. (2016). Identification of the pXO1 plasmid in attenuated Bacillus anthracis vaccine strains. Virulence, 7, 578–586
doi: 10.1080/21505594.2016.1164366
Schade, R., Calzado, E. G., Sarmiento, R., Chacana, P. A., Porankiewicz-Asplund, J., & Terzolo, H. R. (2005). Chicken egg yolk antibodies (IgY-technology): A review of progress in production and use in research and human and veterinary medicine. Alternatives to Laboratory Animals, 33, 129–154
doi: 10.1177/026119290503300208

Auteurs

Swati Banger (S)

Bioprocess Technology Division, Defence Research and Development Establishment, Jhansi Road, Gwalior, 474002, India.

Vijai Pal (V)

Bioprocess Technology Division, Defence Research and Development Establishment, Jhansi Road, Gwalior, 474002, India.

N K Tripathi (NK)

Bioprocess Technology Division, Defence Research and Development Establishment, Jhansi Road, Gwalior, 474002, India.

A K Goel (AK)

Bioprocess Technology Division, Defence Research and Development Establishment, Jhansi Road, Gwalior, 474002, India. akgoel73@yahoo.co.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH